Abstracts Archive - Page 70 of 1683 - ATC Abstracts

2022 American Transplant Congress
Dendritic Cell Senescence as a Key Contributor to Transplant Rejection
J. Zhao¹, X. Li¹, S. Jung¹, H. Zhang¹, V. Kasinath¹, J. Azzi¹, P. Sage¹, J. Bromberg², R. Abdi¹
¹Brigham and Women’s Hospital, Boston, MA, ²University of Maryland School of Medicine, Baltimore, MD
*Purpose: Intra-graft inflammation initiated by ischemia-reperfusion injury (IRI) is an unavoidable consequence of transplantation surgery and constitutes a key source of alloimmune responses. IRI leads…
2022 American Transplant Congress
Exploration of the Optimal pH in Hypothermic Machine Perfusion for Rat Liver Grafts Retrieved from Circulatory Death
S. Sakamoto¹, M. Fukai¹, K. Shibata¹, H. Bochimoto², N. Mohd Zin², N. Kawamura¹, T. Ishikawa¹, M. Fujiyoshi¹, T. Shimamura³, A. Taketomi¹
¹Department of Gastroenterological Surgery 1, Hokkaido University Graduate School, Sapporo, Japan, ²Department of Cell Physiology, The Jikei University School of Medicine, Tokyo, Japan, ³Division of Organ Transplantation, Hokkaido University Hospital, Sapporo, Japan
*Purpose: Although some investigators have reported favorable results of hypothermic machine perfusion (HMP) in liver transplantation, the efficacy to the hepatic graft retrieved from circulatory…
2022 American Transplant Congress
Outcomes in Kidney Transplant Recipients 70 Years and Older
J. Mehta, N. F. Okonkwo, A. Paramesh, K. Atiemo, M. Killackey, H. Jeon, A. Vijay
Tulane University School of Medicine, New Orleans, LA
*Purpose: Patients older than 70 years are the fastest-growing age group of patients requiring renal replacement therapy. This has resulted in a corresponding increase in…
2022 American Transplant Congress
An Updated Estimate of Post-Transplant Survival After Implementation of the New Donor Heart Allocation Policy
K. A. Lazenby¹, N. Narang², K. M. Pelzer³, G. Ran¹, W. F. Parker³
¹Pritzker School of Medicine, University of Chicago, Chicago, IL, ²Advocate Heart Institute, Advocate Christ Medical Center, Chicago, IL, ³Department of Medicine, University of Chicago, Chicago, IL
*Purpose: Published estimates showing lower post-transplant survival after implementation of the new heart allocation policy may be biased downward due to incomplete follow-up on surviving…
2022 American Transplant Congress
Clinical Relevance of Class II HLA Mismatches in Living Donor Kidney Transplantation
J. Lan¹, M. Kadatz¹, D. Chang¹, R. Liwski², E. Wagner², P. Campbell², J. Gill¹, J. Gill¹
¹University of British Columbia, Vancouver, BC, Canada, ²On behalf of Canadian HLA Advisory Committee, Ottawa, ON, Canada
*Purpose: The benefit of class II HLA matching is primarily shown in deceased donor kidney transplantation. The objective of this study was to determine the…
2022 American Transplant Congress
Pharmacogenomic Dosing in Kidney Transplant Patients Converted from Tacrolimus Immediate Release to Tacrolimus Extended Release (Envarsus XR®)
K. D. Belfield¹, K. J. Armstrong², D. Malhotra³, G. F. Girone¹
¹Department of Pharmacy, Yale New Haven Hospital, New Haven, CT, ²Department of Pharmacy, Hospital of Central Connecticut, New Britain, CT, ³Section of Nephrology, Yale School of Medicine, New Haven, CT
*Purpose: When converting from tacrolimus (tac) immediate release (tacIR) to tac extended release (Envarsus XR; tacXR), the package insert (PI) recommends 80% of the tacIR…
2022 American Transplant Congress
Clinical Outcomes In A Large Transplant Cohort Hospitalized With COVID-19: Mycophenolate Mofetil (MMF) Utilization And Mortality Trends
R. L. Gottlieb¹, M. Askar², L. Chen³, A. Chandak⁴, E. Mozaffari³, M. Thrun³, R. Haubrich³
¹Baylor Scott & White Research Institute, Dallas, TX, ²Baylor University Medical Center, Dallas, TX, ³Gilead Sciences, Foster City, CA, ⁴Certara, New York, NY
*Purpose: To characterize demographics, treatment patterns, and outcomes among 3,998 transplant patients hospitalized for COVID-19 over 16 months of the pandemic (May ’20-Aug ’21).*Methods: Adult…
2022 American Transplant Congress
Improving Access and Equity for Transplant: A Single-Center Experience
S. Kodali¹, A. Lopez², C. Egwim², J. Alegria², S. Yi², H. Adrogue², M. Moaddab², H. Huang², I. Hussain², M. Kassi², J. Ontiveros², R. Guardiola², J. Alexander², D. Harvey², K. Maresh², S. Zylicz², L. Loza², J. Corkrean², A. O. Gaber², R. M. Ghobrial¹
¹Sherrie and Alan Conover Center for Liver Disease & Transplantation, Houston Methodist Hospital, Houston, TX, ²Houston Methodist Hospital, Houston, TX
*Purpose: Many Hispanic Americans have misconceptions about transplantation due to language and cultural differences, which can make them less likely to undergo liver transplant (LT)…
2022 American Transplant Congress
Ventricular Modeling Following Bariatric Surgery Decreases Need for Heart Transplantation
R. Choudhury¹, A. Rouhi², G. Hoeltzel³, Y. Bababekov¹, A. Suarez-Pierre⁴, A. Yule¹, N. Vigneshwar⁴, N. Williams⁵, K. Dumon², T. Nydam¹
¹Transplantation Surgery, University of Colorado Hospital, Aurora, CO, ²General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, ³General Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, ⁴Cardiothoracic Surgery, University of Colorado Hospital, Aurora, CO, ⁵General Surgery, Hospital of the University of Pennsylvania, Aurora, CO
*Purpose: For obese patients with congestive heart failure (CHF), aggressive weight loss has been associated with ventricular remodeling. Many have suggested offering bariatric surgery for…
2022 American Transplant Congress
Comparison of Outcomes of Covid-19 Between Fully Vaccinated and Unvaccinated Kidney Transplant Recipients and According to the Type of M-RNA Vaccine
F. Villanego¹, M. Crespo², V. Lopez³, S. Zarraga⁴, F. Oppenheimer⁵, L. Llinas², A. Andres⁶, C. Diaz⁷, M. Ruiz⁸, F. Moreso⁹, A. Rodriguez-Benot¹⁰, I. Beneyto¹¹, S. Cabello¹², C. Jimenez¹³, C. Canal¹⁴, M. Molina¹⁵, J. Pascual⁶, A. Mazuecos¹
¹Department of Nephrology, Hospital Puerta del Mar, Cadiz, Spain, ²Department of Nephrology, Hospital del Mar, Barcelona, Spain, ³Department of Nephrology, Hospital Regional de Malaga, Malaga, Spain, ⁴Department of Nephrology, Hospital de Cruces, Baracaldo, Spain, ⁵Department of Nephrology, Hospital Clinic, Barcelona, Spain, ⁶Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain, ⁷Department of Nephrology, Hospital Central de Asturias, Oviedo, Spain, ⁸Department of Nephrology, Hospital Virgen de las Nieves, Granada, Spain, ⁹Department of Nephrology, Hospital Vall d'Hebron, Barcelona, Spain, ¹⁰Department of Nephrology, Hospital Reina Sofia, Cordoba, Spain, ¹¹Department of Nephrology, Hospital La Fe, Valencia, Spain, ¹²Department of Nephrology, Hospital Son Espases, Palma de Mallorca, Spain, ¹³Department of Nephrology, Hospital La Paz, Madrid, Spain, ¹⁴Department of Nephrology, Fundacion Puigvert, Barcelona, Spain, ¹⁵Department of Nephrology, Hospital Germans Trias i Pujol, Badalona, Spain
*Purpose: The evidence regarding the clinical effectiveness of COVID-19 vaccination in kidney transplant (KT) recipients is limited so far. Our purpose is to analyze the…